Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GNS561 is an inhibitor of autophagy.1 It inhibits palmitoyl-protein thioesterase 1 (PPT1) and autophagic flux, increases lysosomal zinc(II) levels, and induces apoptosis in HepG2 hepatocellular carcinoma (HCC) cells. GNS561 reduces viability in a panel of 17 human cancer cells (IC50s = 0.22-7.27 µM) and reduces alpha fetoprotein serum levels and tumor volume and weight in a patient-derived xenograft (PDX) mouse model of HCC. It also inhibits replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Vero E6 cells (EC50 = 0.04 µM) and reduces lung viral titers in a mouse model of SARS-CoV-2 infection.2
WARNING This product is not for human or veterinary use.
1. GNS561, a clinical-
2. GNS561 exhibits potent antiviral activity against SARS-